Imperial College London
Portrait Picture

Dr. David James PINATO

Faculty of Medicine, Department of Surgery & Cancer

Clinical Reader in Medical Oncology
 
 
 
//

Contact

 

+44 (0)20 7594 2799david.pinato Website

 
 
//

Location

 

ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{D'Alessio:2022:10.1002/hep.32468,
author = {D'Alessio, A and Weinmann, A and Galle, P and Gaillard, V and Fulgenzi, CAM and Bettinger, D and Bengsch, B and Vogel, A and Balcar, L and Scheiner, B and Amara, S and Muzaffar, M and Naqash, AR and Personeni, N and Pressiani, T and Sharma, R and Pinter, M and Cortellini, A and Rimassa, L and Pinato, DJ},
doi = {10.1002/hep.32468},
journal = {JOURNAL OF HEPATOLOGY},
pages = {S376--S376},
title = {Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study},
url = {http://dx.doi.org/10.1002/hep.32468},
volume = {77},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AU  - D'Alessio,A
AU  - Weinmann,A
AU  - Galle,P
AU  - Gaillard,V
AU  - Fulgenzi,CAM
AU  - Bettinger,D
AU  - Bengsch,B
AU  - Vogel,A
AU  - Balcar,L
AU  - Scheiner,B
AU  - Amara,S
AU  - Muzaffar,M
AU  - Naqash,AR
AU  - Personeni,N
AU  - Pressiani,T
AU  - Sharma,R
AU  - Pinter,M
AU  - Cortellini,A
AU  - Rimassa,L
AU  - Pinato,DJ
DO  - 10.1002/hep.32468
EP  - 376
PY  - 2022///
SN  - 0168-8278
SP  - 376
TI  - Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: a real-world study
T2  - JOURNAL OF HEPATOLOGY
UR  - http://dx.doi.org/10.1002/hep.32468
UR  - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000826275102102&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb
VL  - 77
ER  -
Download